Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,103,486
-$294,119 QoQ
Shares Held
25,867
-10.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#242
of 712 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Strategic Investment Advisors / MI holds $15,039,322 across 11 Drug Manufacturers - General names. SNY ranks #6 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
14,165 | $3,564,480 | |
| 2 | LLY |
ELI LILLY & Co
|
2,376 | $2,849,845 | |
| 3 | AMGN |
Amgen Inc
|
7,664 | $2,775,287 | |
| 4 | PFE |
Pfizer Inc
|
48,044 | $1,156,899 | |
| 5 | JNJ |
Johnson & Johnson
|
4,524 | $1,148,960 | |
| 6 | SNY |
Sanofi
This page
|
25,867 | $1,103,486 | |
| 7 | MRK |
Merck & Co., Inc.
|
6,694 | $860,179 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,340 | $674,655 |
All Filings in SNY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,103,486 | 25,867 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,397,605 | 29,008 | Shares | Sole | 2026-05-18 | |
| No filing history on record for this holder in this stock. | ||||||